185 related articles for article (PubMed ID: 36973536)
41. National trends for axillary lymph node dissection and survival outcomes for clinical T3/T4 node-negative breast cancer patients undergoing mastectomy with positive lymph nodes.
Reyna C; Johnston ME; Morris MC; Lee TC; Hanseman D; Shaughnessy EA; Lewis JD
Breast Cancer Res Treat; 2021 Aug; 189(1):155-166. PubMed ID: 34143359
[TBL] [Abstract][Full Text] [Related]
42. Omitting axillary lymph node dissection after positive sentinel lymph node in the post-Z0011 era: Compliance with NCCN and ASCO clinical guidelines and Z0011 criteria in a large prospective cohort.
Costaz H; Boulle D; Bertaut A; Rouffiac M; Beltjens F; Desmoulins I; Peignaux K; Ladoire S; Causeret S; Loustalot C; Padeano MM; Vincent L; Jankowski C; Arnould L; Coutant C
Bull Cancer; 2022 Mar; 109(3):268-279. PubMed ID: 34838310
[TBL] [Abstract][Full Text] [Related]
43. Comparing Early-Stage Breast Cancer Patients with Sentinel Lymph Node Metastasis with and without Completion Axillary Lymph Node Dissection: A Systematic Review and Meta-Analysis.
Heiranizadeh N; Rafiei Shahamabadi M; Dehghan HR; Jafari-Nedooshan J; Kargar S; Zare M; Amooei A; Shiryazdi SM; Broomand MA; Moravej MT; Sadri Z
Asian Pac J Cancer Prev; 2022 Aug; 23(8):2561-2571. PubMed ID: 36037108
[TBL] [Abstract][Full Text] [Related]
44. Treatment and survival of patients with occult breast cancer with axillary lymph node metastasis: a nationwide retrospective study.
Sohn G; Son BH; Lee SJ; Kang EY; Jung SH; Cho SH; Baek S; Lee YR; Kim HJ; Ko BS; Yu ; Lee JW; Ahn SH
J Surg Oncol; 2014 Sep; 110(3):270-4. PubMed ID: 24863883
[TBL] [Abstract][Full Text] [Related]
45. Axillary lymph node dissection is not obligatory in breast cancer patients with biopsy-proven axillary lymph node metastasis.
Yoo TK; Kang BJ; Kim SH; Song BJ; Ahn J; Park WC; Chae BJ
Breast Cancer Res Treat; 2020 Jun; 181(2):403-409. PubMed ID: 32328848
[TBL] [Abstract][Full Text] [Related]
46. Trade-offs associated with axillary lymph node dissection with breast irradiation versus breast irradiation alone in patients with a positive sentinel node in relation to the risk of non-sentinel node involvement: implications of ACOSOG Z0011.
Krishnan MS; Recht A; Bellon JR; Punglia RS
Breast Cancer Res Treat; 2013 Feb; 138(1):205-13. PubMed ID: 23338762
[TBL] [Abstract][Full Text] [Related]
47. Axillary surgery and complication rates after mastectomy and reconstruction for breast cancer: an analysis of the NSQIP database.
Bogach J; Cordeiro E; Reel E; Cil TD
Breast Cancer Res Treat; 2022 Apr; 192(3):501-508. PubMed ID: 35152347
[TBL] [Abstract][Full Text] [Related]
48. Axillary nodal metastases in Italian early breast cancer patients with positive sentinel lymph node: can axillary node dissection be avoided by using predictive nomograms?
Biolchini F; Vicentini M; Di Felice E; Giovanardi F; Antonio L; Giorgi Rossi P; Annessi V
Tumori; 2015; 101(3):298-305. PubMed ID: 25838248
[TBL] [Abstract][Full Text] [Related]
49. Long-term survival after sentinel lymph node biopsy or axillary lymph node dissection in pN0 breast cancer patients: a population-based study.
Zheng Q; Luo H; Xia W; Lu Q; Jiang K; Hong R; Xu F; Wang S
Breast Cancer Res Treat; 2022 Dec; 196(3):613-622. PubMed ID: 36207619
[TBL] [Abstract][Full Text] [Related]
50. A longitudinal comparison of arm morbidity in stage I-II breast cancer patients treated with sentinel lymph node biopsy, sentinel lymph node biopsy followed by completion lymph node dissection, or axillary lymph node dissection.
Kootstra JJ; Hoekstra-Weebers JE; Rietman JS; de Vries J; Baas PC; Geertzen JH; Hoekstra HJ
Ann Surg Oncol; 2010 Sep; 17(9):2384-94. PubMed ID: 20221902
[TBL] [Abstract][Full Text] [Related]
51. Implementation of sentinel node biopsy in breast cancer patients in the Netherlands.
Ho VK; van der Heiden-van der Loo M; Rutgers EJ; van Diest PJ; Hobbelink MG; Tjan-Heijnen VC; Dirx MJ; Reedijk AM; van Dijck JA; van de Poll-Franse LV; Schaapveld M; Peeters PH
Eur J Cancer; 2008 Mar; 44(5):683-91. PubMed ID: 18314328
[TBL] [Abstract][Full Text] [Related]
52. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
Tvedskov TF
Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850
[TBL] [Abstract][Full Text] [Related]
53. The evolution of the sentinel node procedure in the treatment of breast cancer.
Tvedskov TF
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975889
[TBL] [Abstract][Full Text] [Related]
54. Sentinel node biopsy in early breast cancer: lessons learned from more than 1000 cases at a single institution.
Fancellu A; Cottu P; Feo CF; Bertulu D; Giuliani G; Mulas S; Sanna V; Mura S; Madeddu G; Spanu A
Tumori; 2012; 98(4):413-20. PubMed ID: 23052155
[TBL] [Abstract][Full Text] [Related]
55. Impact of axillary ultrasound (AUS) on axillary dissection in breast conserving surgery (BCS).
Reyna C; Kiluk JV; Frelick A; Khakpour N; Laronga C; Lee MC
J Surg Oncol; 2015 Jun; 111(7):813-8. PubMed ID: 25753101
[TBL] [Abstract][Full Text] [Related]
56. Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.
Giuliano AE; Ballman KV; McCall L; Beitsch PD; Brennan MB; Kelemen PR; Ollila DW; Hansen NM; Whitworth PW; Blumencranz PW; Leitch AM; Saha S; Hunt KK; Morrow M
JAMA; 2017 Sep; 318(10):918-926. PubMed ID: 28898379
[TBL] [Abstract][Full Text] [Related]
57. Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive breast cancer patients: experience from the SEER database.
Yi M; Giordano SH; Meric-Bernstam F; Mittendorf EA; Kuerer HM; Hwang RF; Bedrosian I; Rourke L; Hunt KK
Ann Surg Oncol; 2010 Oct; 17 Suppl 3(0 3):343-51. PubMed ID: 20853057
[TBL] [Abstract][Full Text] [Related]
58. Axillary Surgery for Early-Stage, Node-Positive Mastectomy Patients and the Use of Postmastectomy Chest Wall Radiation Therapy.
Gaines S; Suss N; Barrera E; Pesce C; Kuchta K; Winchester DJ; Yao K
Ann Surg Oncol; 2018 Aug; 25(8):2220-2228. PubMed ID: 29626303
[TBL] [Abstract][Full Text] [Related]
59. Preservation of Axillary Lymph Nodes Compared with Complete Dissection in T1-2 Breast Cancer Patients Presenting One or Two Metastatic Sentinel Lymph Nodes: The SINODAR-ONE Multicenter Randomized Clinical Trial.
Tinterri C; Gentile D; Gatzemeier W; Sagona A; Barbieri E; Testori A; Errico V; Bottini A; Marrazzo E; Dani C; Dozin B; Boni L; Bruzzi P; Fernandes B; Franceschini D; Spoto R; Torrisi R; Scorsetti M; Santoro A; Canavese G;
Ann Surg Oncol; 2022 Sep; 29(9):5732-5744. PubMed ID: 35552930
[TBL] [Abstract][Full Text] [Related]
60. Independent risk factors for axillary lymph node metastasis in breast cancer patients with one or two positive sentinel lymph nodes.
Zhang W; Xu J; Wang K; Tang XJ; Liang H; He JJ
BMC Womens Health; 2020 Jul; 20(1):143. PubMed ID: 32646416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]